The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/8791047

Download in:

View as

General Info

PMID
8791047